{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:24Z","timestamp":1792787844307,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tianjin Health Research Project","award":["JWJ2023MS057"],"award-info":[{"award-number":["JWJ2023MS057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Sarcopenia increased the risk of various adverse outcomes, including cardiovascular diseases, falls, and mortality. Implementing interventions could mitigate the harm caused by sarcopenia. With the dearth of health economics evaluation on sarcopenia screening, we aimed to evaluate the costs and benefits of sarcopenia screening strategies among community-dwelling older persons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We constructed a decision-analytic Markov model for a cohort of individuals aged 60 years and above with a total of 25 1-year cycles. A total of 20 screening strategies, with annual or biennial screening interval and 10 screening tools: SARC-F, MSRA-5, MSRA-7, calf circumference, Finger-ring test, Ishii test, SARC-CALF, AWGS 2019, SARC-F|MSRA-5 (Parallel test), and SARC-F|MSRA-7 (Parallel test), were assessed in our study. Cost-effectiveness analysis was conducted by calculating the cost, quality-adjusted life-years (QALYs) for each strategy. The corresponding incremental cost-effectiveness ratio (ICER) was obtained by comparing with no screening. Highly cost-effective strategies were considered if ICER was less than the per-capita GDP for China ($12,551.49), and the strategy with the lowest ICER was the most cost-effective. One-way deterministic and probabilistic sensitivity analyses (DSA &amp; PSA) were used to assess the robustness of the main outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with no screening, all screening strategies were highly cost-effective. The most cost-effective screening strategy was biennial SARC-F|MSRA-7 screening ($1461.52\/QALY), followed by annual SARC-F|MSRA-7 screening ($2147.82\/QALY), biennial AWGS 2019 screening ($2340.21\/QALY), and annual AWGS 2019 screening ($2419.16\/QALY). DSA results indicated that the model was relatively stable. PSA results indicated that the probability of annual AWGS 2019 screening being cost-effective increased to 100%, when the willing-to-pay threshold increased to $9800.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Combining the PSA results, we recommended conducting annual sarcopenia screening with AWGS 2019 among community-dwelling older adults in China.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-25263-x","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:52:34Z","timestamp":1762519954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Health economics evaluation of screening for sarcopenia among community-dwelling older persons"],"prefix":"10.1186","volume":"25","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanliang","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"4","key":"25263_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412\u201323.","journal-title":"Age Ageing"},{"key":"25263_CR2","first-page":"1","volume":"457","author":"L Larsson","year":"1978","unstructured":"Larsson L. Morphological and functional characteristics of the ageing skeletal muscle in man. A cross-sectional study. Acta Physiol Scandinavica Suppl. 1978;457:1\u201336.","journal-title":"Acta Physiol Scandinavica Suppl"},{"issue":"3","key":"25263_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1748-1716.1983.tb00024.x","volume":"117","author":"L Larsson","year":"1983","unstructured":"Larsson L. Histochemical characteristics of human skeletal muscle during aging. Acta Physiol Scand. 1983;117(3):469\u201371.","journal-title":"Acta Physiol Scand"},{"issue":"4","key":"25263_CR4","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1152\/jappl.2000.88.4.1321","volume":"88","author":"WR Frontera","year":"2000","unstructured":"Frontera WR, Hughes VA, Fielding RA, et al. Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol. 2000;88(4):1321\u20136.","journal-title":"J Appl Physiol"},{"issue":"2\u20133","key":"25263_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0022-510X(88)90132-3","volume":"84","author":"J Lexell","year":"1988","unstructured":"Lexell J, Taylor CC, Sj\u00f6str\u00f6m M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole Vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci. 1988;84(2\u20133):275\u201394.","journal-title":"J Neurol Sci"},{"issue":"3","key":"25263_CR6","first-page":"133","volume":"4","author":"DL Waters","year":"2000","unstructured":"Waters DL, Baumgartner RN, Garry PJ. Sarcopenia: current perspectives. J Nutr Health Aging. 2000;4(3):133\u20139.","journal-title":"J Nutr Health Aging"},{"key":"25263_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s40200-017-0302-x","volume":"16","author":"G Shafiee","year":"2017","unstructured":"Shafiee G, Keshtkar A, Soltani A, et al. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord. 2017;16:21.","journal-title":"J Diabetes Metab Disord"},{"issue":"3","key":"25263_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300\u20137. e2.","journal-title":"J Am Med Dir Assoc"},{"issue":"22","key":"25263_CR9","first-page":"4109","volume":"46","author":"LJ Wu","year":"2019","unstructured":"Wu LJ, Li JX. Prevalence of sarcopenia in the community-dwelling elder people in China: a systematic review and meta-analysis. Mod Prev Med. 2019;46(22):4109\u201312.","journal-title":"Mod Prev Med"},{"issue":"6","key":"25263_CR10","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1002\/jcsm.13081","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Peng W, Ren R, et al. Sarcopenia and mild cognitive impairment among elderly adults: the first longitudinal evidence from CHARLS. J Cachexia Sarcopenia Muscle. 2022;13(6):2944\u201352.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"25263_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101264","volume":"44","author":"K Gao","year":"2022","unstructured":"Gao K, Cao LF, Ma WZ, et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China health and retirement longitudinal study. EClinicalMedicine. 2022;44:101264.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"25263_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jcsm.12411","volume":"10","author":"SSY Yeung","year":"2019","unstructured":"Yeung SSY, Reijnierse EM, Pham VK, et al. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2019;10(3):485\u2013500.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"25263_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.14283\/jfa.2019.10","volume":"8","author":"S Goates","year":"2019","unstructured":"Goates S, Du K, Arensberg MB, et al. Economic impact of hospitalizations in US adults with sarcopenia. J Frailty Aging. 2019;8(2):93\u20139.","journal-title":"J Frailty Aging"},{"issue":"4","key":"25263_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.clnu.2009.12.006","volume":"29","author":"F Landi","year":"2010","unstructured":"Landi F, Russo A, Liperoti R, et al. Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Clin Nutr. 2010;29(4):441\u20137.","journal-title":"Clin Nutr"},{"issue":"2","key":"25263_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/ageing\/afs194","volume":"42","author":"F Landi","year":"2013","unstructured":"Landi F, Cruz-Jentoft AJ, Liperoti R, et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from IlSIRENTE study. Age Ageing. 2013;42(2):203\u20139.","journal-title":"Age Ageing"},{"issue":"2","key":"25263_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/wvn.12147","volume":"13","author":"SF Chang","year":"2016","unstructured":"Chang SF, Lin PL. Systematic literature review and meta-analysis of the association of sarcopenia with mortality. Worldviews on Evidence-Based Nursing. 2016;13(2):153\u201362.","journal-title":"Worldviews on Evidence-Based Nursing"},{"issue":"12","key":"25263_CR17","doi-asserted-by":"publisher","first-page":"e907","DOI":"10.1016\/S2468-2667(21)00231-0","volume":"6","author":"P Ye","year":"2021","unstructured":"Ye P, Er Y, Wang H, et al. Burden of falls among people aged 60 years and older in Mainland China, 1990\u20132019: findings from the global burden of disease study 2019. Lancet Public Health. 2021;6(12):e907\u201318.","journal-title":"Lancet Public Health"},{"issue":"1","key":"25263_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1532-5415.2004.52014.x","volume":"52","author":"I Janssen","year":"2004","unstructured":"Janssen I, Shepard DS, Katzmarzyk PT, et al. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80\u20135.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"25263_CR19","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jamda.2020.03.018","volume":"21","author":"M Kim","year":"2020","unstructured":"Kim M, Won CW. Sarcopenia in Korean community-dwelling adults aged 70 years and older: application of screening and diagnostic tools from the Asian working group for sarcopenia 2019 update. J Am Med Dir Assoc. 2020;21(6):752\u20138.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"25263_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36585-4","volume":"13","author":"SG Kandinata","year":"2023","unstructured":"Kandinata SG, Widajanti N, Ichwani J, et al. Diagnostic performance of calf circumference, SARC-F, and SARC-CalF for possible sarcopenia screening in Indonesia. Sci Rep. 2023;13(1):9824.","journal-title":"Sci Rep"},{"issue":"4","key":"25263_CR21","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jamda.2020.05.041","volume":"22","author":"YH Mo","year":"2021","unstructured":"Mo YH, Zhong J, Dong X, et al. Comparison of three screening methods for sarcopenia in Community-Dwelling older persons. J Am Med Dir Assoc. 2021;22(4):746\u201350. e1.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"25263_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jamda.2018.04.012","volume":"20","author":"M Yang","year":"2019","unstructured":"Yang M, Hu X, Xie L, et al. Comparing mini sarcopenia risk assessment with SARC-F for screening sarcopenia in community-dwelling older adults. J Am Med Dir Assoc. 2019;20(1):53\u20137.","journal-title":"J Am Med Dir Assoc"},{"issue":"Suppl 1","key":"25263_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/ggi.12197","volume":"14","author":"S Ishii","year":"2014","unstructured":"Ishii S, Tanaka T, Shibasaki K, et al. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int. 2014;14(Suppl 1):93\u2013101.","journal-title":"Geriatr Gerontol Int"},{"issue":"12","key":"25263_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061613","volume":"12","author":"H Fujii","year":"2022","unstructured":"Fujii H, Kodani E, Kaneko T, et al. Sarcopenia and coexistent risk factors detected using the Yubi-wakka (finger-ring) test in adults aged over 65 years in the public annual health check-up in Tama City, tokyo: a cross-sectional study. BMJ Open. 2022;12(12):e061613.","journal-title":"BMJ Open"},{"issue":"1","key":"25263_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-10511-7","volume":"21","author":"A Darvishi","year":"2021","unstructured":"Darvishi A, Hemami MR, Shafiee G, et al. Sarcopenia screening strategies in older people: a cost effectiveness analysis in Iran. BMC Public Health. 2021;21(1):926.","journal-title":"BMC Public Health"},{"issue":"8","key":"25263_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/geroni\/igad105","volume":"7","author":"B Sun","year":"2023","unstructured":"Sun B, Li S, Wang Y, et al. Sarcopenia transitions and influencing factors among Chinese older adults with multistate Markov model. Innov Aging. 2023;7(8):igad105.","journal-title":"Innov Aging"},{"issue":"1","key":"25263_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19466315.2017.1349689","volume":"10","author":"K Maruo","year":"2018","unstructured":"Maruo K, Tada K, Ishii R, et al. An efficient procedure for calculating sample size through statistical simulations. Stat Biopharm Res. 2018;10(1):1\u20138.","journal-title":"Stat Biopharm Res"},{"issue":"1","key":"25263_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7547-1-8","volume":"1","author":"R Hutubessy","year":"2003","unstructured":"Hutubessy R, Chisholm D, Edejer TTT. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Eff Resour Alloc. 2003;1(1):8.","journal-title":"Cost Eff Resour Alloc"},{"issue":"10","key":"25263_CR29","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s12603-016-0704-3","volume":"20","author":"P Han","year":"2016","unstructured":"Han P, Zhao J, Guo Q, et al. Incidence, risk factors, and the protective effect of high body mass index against sarcopenia in suburb-dwelling elderly Chinese populations. J Nutr Health Aging. 2016;20(10):1056\u201360.","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"25263_CR30","first-page":"134","volume":"17","author":"Y Jiang","year":"2013","unstructured":"Jiang Y, Xia QH, Hu J, et al. Study on the epidemical characteristics and disease burden of fall-related injury among community-dwelling elderly adults in Changning district, Shanghai. Chin J Disease Control Prev. 2013;17(2):134\u20137.","journal-title":"Chin J Disease Control Prev"},{"issue":"4","key":"25263_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000517099","volume":"68","author":"J Xu","year":"2022","unstructured":"Xu J, Wan CS, Ktoris K, et al. Sarcopenia is associated with mortality in adults: a systematic review and meta-analysis. Gerontology. 2022;68(4):361\u201376.","journal-title":"Gerontology"},{"key":"25263_CR32","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2147\/CIA.S132940","volume":"12","author":"M Steffl","year":"2017","unstructured":"Steffl M, Bohannon RW, Sontakova L, et al. Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis. Clin Interv Aging. 2017;12:835\u201345.","journal-title":"Clin Interv Aging"},{"issue":"2","key":"25263_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1447-0594.2012.00923.x","volume":"13","author":"H Kim","year":"2013","unstructured":"Kim H, Suzuki T, Saito K, et al. Effects of exercise and tea catechins on muscle mass, strength and walking ability in community-dwelling elderly Japanese sarcopenic women: a randomized controlled trial. Geriatr Gerontol Int. 2013;13(2):458\u201365.","journal-title":"Geriatr Gerontol Int"},{"issue":"3","key":"25263_CR34","first-page":"327","volume":"30","author":"Y Liu","year":"2024","unstructured":"Liu Y, Sun BR, Liu XW, et al. Diagnostic accuracy of screening tools for sarcopenia among the community-dwelling elderly: a Meta-analysis. Chin J Osteoporos. 2024;30(3):327\u201334.","journal-title":"Chin J Osteoporos"},{"key":"25263_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1310383","volume":"12","author":"S Qian","year":"2024","unstructured":"Qian S, Zhang S, Lu M, et al. The accuracy of screening tools for sarcopenia in older Chinese adults: a systematic review and meta-analysis. Front Public Health. 2024;12:1310383.","journal-title":"Front Public Health"},{"issue":"2","key":"25263_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/nu13020635","volume":"13","author":"AP Rossi","year":"2021","unstructured":"Rossi AP, Caliari C, Urbani S, et al. Sarcopenia risk evaluation in a sample of hospitalized elderly men and women: combined use of the mini sarcopenia risk assessment (MSRA) and the SARC-F. Nutrients. 2021;13(2):635.","journal-title":"Nutrients"},{"issue":"10","key":"25263_CR37","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jama.2016.12195","volume":"316","author":"GD Sanders","year":"2016","unstructured":"Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316(10):1093\u2013103.","journal-title":"JAMA"},{"issue":"3","key":"25263_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11136-010-9762-x","volume":"20","author":"S Sun","year":"2011","unstructured":"Sun S, Chen J, Johannesson M, the National Health Services Survey 2008. Population health status in china: EQ-5D results, by age, sex and socio-economic status, from. Qual Life Research: Int J Qual Life Aspects Treat Care Rehabilitation. 2011;20(3):309\u201320.","journal-title":"Qual Life Research: Int J Qual Life Aspects Treat Care Rehabilitation"},{"key":"25263_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00456","volume":"11","author":"R You","year":"2020","unstructured":"You R, Zhang Y, Wu DBC, et al. Cost-effectiveness of Zoledronic acid versus oral alendronate for postmenopausal osteoporotic women in China. Front Pharmacol. 2020;11:456.","journal-title":"Front Pharmacol"},{"issue":"7","key":"25263_CR40","first-page":"115","volume":"58","author":"Q Deng","year":"2020","unstructured":"Deng Q, Liu WB. Multilevel analysis of health related quality of life of patients with cardiovascular disease and its determinants. J Shandong University(Health Sciences). 2020;58(7):115\u201321.","journal-title":"J Shandong University(Health Sciences)"},{"issue":"10","key":"25263_CR41","first-page":"763","volume":"29","author":"JM Liu","year":"2020","unstructured":"Liu JM, Wang DD, Lu PP, et al. Direct medical costs of upper Gastrointestinal cancer endoscopic screening in Shandong Province in 2018. China Cancer. 2020;29(10):763\u20137.","journal-title":"China Cancer"},{"issue":"9","key":"25263_CR42","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1111\/jgs.16041","volume":"67","author":"SP Juraschek","year":"2019","unstructured":"Juraschek SP, Daya N, Appel LJ, et al. Subclinical cardiovascular disease and fall risk in older adults: results from the atherosclerosis risk in communities study. J Am Geriatr Soc. 2019;67(9):1795\u2013802.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"25263_CR43","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.clinthera.2024.08.016","volume":"46","author":"J Nie","year":"2024","unstructured":"Nie J, Liu L, Wu H, et al. Cost-effectiveness of zanubrutinib versus bendamustine and rituximab in patients with untreated chronic lymphocytic leukemia. Clin Ther. 2024;46(11):877\u201382.","journal-title":"Clin Ther"},{"key":"25263_CR44","unstructured":"World Health Statistics. 2022 report. https:\/\/www.who.int\/data\/gho\/publications\/world-health-statistics. Retrieved May 20, 2022."},{"issue":"1","key":"25263_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/ageing\/afz125","volume":"49","author":"M Franklin","year":"2019","unstructured":"Franklin M, Hunter RM. A modelling-based economic evaluation of primary-care-based fall-risk screening followed by fall-prevention intervention: a cohort-based Markov model stratified by older age groups. Age Ageing. 2019;49(1):57\u201366.","journal-title":"Age Ageing"},{"issue":"2","key":"25263_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","volume":"15","author":"LK Chen","year":"2014","unstructured":"Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc. 2014;15(2):95\u2013101.","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"25263_CR47","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/gerona\/glt131","volume":"69","author":"RA Murphy","year":"2014","unstructured":"Murphy RA, Ip EH, Zhang Q, et al. Transition to sarcopenia and determinants of transitions in older adults: a population-based study. J Gerontol A Biol Sci Med Sci. 2014;69(6):751\u20138.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"25263_CR48","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/jcsm.12875","volume":"13","author":"C Trevisan","year":"2022","unstructured":"Trevisan C, Vetrano DL, Calvani R, et al. Twelve-year sarcopenia trajectories in older adults: results from a population-based study. J Cachexia Sarcopenia Muscle. 2022;13(1):254\u201363.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"Supplement1","key":"25263_CR49","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/geroni\/igae098.3089","volume":"8","author":"Y Jung","year":"2024","unstructured":"Jung Y, Wu K, Alnufeay M, et al. Cost effectiveness analysis of implementing a screening program for early-stage Alzheimer\u2019s disease detection. Innov Aging. 2024;8(Supplement1):958\u20139.","journal-title":"Innov Aging"},{"issue":"12","key":"25263_CR50","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3346\/jkms.2015.30.12.1723","volume":"30","author":"SW Kim","year":"2015","unstructured":"Kim SW, Kang GW. Cost-utility analysis of screening strategies for diabetic retinopathy in Korea. J Korean Med Sci. 2015;30(12):1723\u201332.","journal-title":"J Korean Med Sci"},{"issue":"6","key":"25263_CR51","volume":"31","author":"F Gheysariyeha","year":"2022","unstructured":"Gheysariyeha F, Rahimi F, Tabesh E, et al. Cost-effectiveness of colorectal cancer screening strategies: a systematic review. Eur J Cancer Care. 2022;31(6):e13673.","journal-title":"Eur J Cancer Care"},{"issue":"1","key":"25263_CR52","doi-asserted-by":"publisher","first-page":"69","DOI":"10.15605\/jafes.039.01.03","volume":"39","author":"FB Rivera","year":"2024","unstructured":"Rivera FB, Escolano BT, Nifas FM, et al. Interrelationship of sarcopenia and cardiovascular diseases: a review of potential mechanisms and management. J ASEAN Fed Endocr Soc. 2024;39(1):69\u201378.","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"2","key":"25263_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/nu17020282","volume":"17","author":"D Anagnostou","year":"2025","unstructured":"Anagnostou D, Theodorakis N, Hitas C, et al. Sarcopenia and cardiogeriatrics: the links between skeletal muscle decline and cardiovascular aging. Nutrients. 2025;17(2):282.","journal-title":"Nutrients"},{"issue":"3","key":"25263_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/XCE.0000000000000193","volume":"9","author":"AJ Sinclair","year":"2020","unstructured":"Sinclair AJ, Abdelhafiz AH. Cardiometabolic disease in the older person: prediction and prevention for the generalist physician. Cardiovasc Endocrinol Metab. 2020;9(3):90\u20135.","journal-title":"Cardiovasc Endocrinol Metab"},{"issue":"9967","key":"25263_CR55","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(14)61347-7","volume":"385","author":"MJ Prince","year":"2015","unstructured":"Prince MJ, Wu F, Guo Y, et al. The burden of disease in older people and implications for health policy and practice. Lancet. 2015;385(9967):549\u201362.","journal-title":"Lancet"},{"key":"25263_CR56","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820953364","volume":"13","author":"S Barr\u00e9","year":"2020","unstructured":"Barr\u00e9 S, Leleu H, Benamouzig R, et al. Cost-effectiveness analysis of alternative colon cancer screening strategies in the context of the French National screening program. Ther Adv Gastroenterol. 2020;13:1756284820953364.","journal-title":"Ther Adv Gastroenterol"},{"issue":"3","key":"25263_CR57","doi-asserted-by":"publisher","first-page":"384","DOI":"10.17269\/s41997-024-00868-8","volume":"115","author":"AA Adegbulugbe","year":"2024","unstructured":"Adegbulugbe AA, Farah E, Ruan Y, et al. The projected health and economic impact of increased colorectal cancer screening participation among Canadians by income quintile. Can J Public Health. 2024;115(3):384\u201394.","journal-title":"Can J Public Health"},{"issue":"5","key":"25263_CR58","doi-asserted-by":"publisher","first-page":"oyaf111","DOI":"10.1093\/oncolo\/oyaf111","volume":"30","author":"T Lyamuya","year":"2025","unstructured":"Lyamuya T, Mchome B, Stroetmann CY, et al. Barriers to adherence to cervical cancer screening care in Northern Tanzania. Oncologist. 2025;30(5):oyaf111.","journal-title":"Oncologist"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25263-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25263-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25263-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:13:14Z","timestamp":1781611994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-025-25263-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25263"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25263-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the ethics committee of Tianjin Medical University (TMUhMEC20240002), whose directives are based on the Helsinki declaration. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3827"}}